CD27/CD27 LIGAND AND T CELL RESPONSES
CD27/CD27 LIGAND AND T CELL RESPONSES
批准号:
2134192
负责人:
GERI R BROWN
金额:
$7.88万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-07-01 至 1999-06-30
关键词:
Adenoviridae CD antigens Crohn's disease cell differentiation chimeric proteins cytokine receptors cytotoxic T lymphocyte delayed hypersensitivity disease /disorder model graft versus host disease helper T lymphocyte laboratory mouse leukocyte activation /transformation primary biliary cirrhosis tissue /cell culture transfection tumor necrosis factor alpha
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CD27, a cell-surface antigen, with homology to tumor necrosis factor (TNF)
receptor family of molecules is found on a majority of T cells and has
been suggested to play a role in T cell activation and generation of
cytotoxic T lymphocytes(CTL). Although elevated levels of soluble CD27
have been demonstrated in serum from patients with rheumatoid arthritis
and other autoimmune disease, the exact role of this T cell activation
antigen in T cell immune responses is still poorly understood. We intend
to establish an in vivo murine model that effectively neutralizes the
CD27/CD27 ligand (CD27L) interaction by the injection of an adenoviral
vector encoding an inhibitor molecule, i.e. a fusion protein formed by
joining the extracellular domain of the murine CD27 receptor to a murine
IgG heavy chain (CD27-Fc). In order to determine the effects of the
neutralization of CD27/CD27L interaction in vivo on CTL, a comparison of
the generation of CTL by primary and secondary intraperitoneal injection
of P815 (H-2d) tumor cells into B6 (H-2b) control mice and mice infected
with the adenovirus containing the CD27-Fc construct will be performed. To
further assess the immunologic importance of the CD27/CD27L system,
evaluation of antigen specific T cell responses and delayed type
hypersensitivity (DTH) responses will be assessed and compared in mice
infected with the adenovirus containing the CD27-Fc inhibitor and control
mice.
CTL play an important role in murine graft versus host disease (GVHD). The
importance of the CD27/CD27L system in the evolution of murine GVHD will
similarly be assessed by comparing control and adenovirus infected animals
in 2 models of GVHD, one that induces bile duct damage and portal
inflammation and simulates lesions in primary biliary cirrhosis utilizing
B6->B6 X BM1 mice; the other inducing extensive colonic inflammatory
lesions similar to those detected in human Crohn's disease utilizing DBA/2
->B6D2F1 mice. All of these studies should better delineate the role of
CD27/CD27L interaction in the evolution of T cell immune responses and
their contribution to the pathogenesis of GVHD.
Finally, the role of TNFR(receptor)/TNF interaction in the evolution of
similar immunologic responses is surprisingly still not well understood.
Comparable assessments of the TNF system in generation of CTL,
contribution to the development of DTH and to GVHD will be performed in
mice in which TNFR/TNF interactions are neutralized by injection of the
adenovirus vector encoding the inhibitor TNFR-Fc, a murine model that was
developed and is already being used in our laboratory.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of TNF receptor family in intestinal GVHD
-
批准号:6765226
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2002
-
负责人:GERI R BROWN
-
依托单位:
The role of TNF receptor family in intestinal GVHD
-
批准号:6603568
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2002
-
负责人:GERI R BROWN
-
依托单位:
The role of TNF receptor family in intestinal GVHD
-
批准号:6546486
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2002
-
负责人:GERI R BROWN
-
依托单位:
ALPHA INTERFERON EFFECT ON GIANT LIVER HEMANGIOMA
-
批准号:6567645
-
项目类别:
-
资助金额:$32.14万
-
财政年份:2001
-
负责人:GERI R BROWN
-
依托单位:
ALPHA INTERFERON EFFECT ON GIANT LIVER HEMANGIOMA
-
批准号:6414493
-
项目类别:
-
资助金额:$32.14万
-
财政年份:2000
-
负责人:GERI R BROWN
-
依托单位:
ALPHA INTERFERON EFFECT ON GIANT LIVER HEMANGIOMA
-
批准号:6117593
-
项目类别:
-
资助金额:$3.48万
-
财政年份:1998
-
负责人:GERI R BROWN
-
依托单位:
ALPHA INTERFERON EFFECT ON GIANT LIVER HEMANGIOMA
-
批准号:6278788
-
项目类别:
-
资助金额:$2.47万
-
财政年份:1997
-
负责人:GERI R BROWN
-
依托单位:
CD27/CD27 LIGAND AND T CELL RESPONSES
-
批准号:2134191
-
项目类别:
-
资助金额:$7.86万
-
财政年份:1994
-
负责人:GERI R BROWN
-
依托单位:
CD27/CD27 LIGAND AND T CELL RESPONSES
-
批准号:2134193
-
项目类别:
-
资助金额:$8.94万
-
财政年份:1994
-
负责人:GERI R BROWN
-
依托单位:
CD27/CD27 LIGAND AND T CELL RESPONSES
-
批准号:2733790
-
项目类别:
-
资助金额:$10.44万
-
财政年份:1994
-
负责人:GERI R BROWN
-
依托单位:
CD27/CD27 LIGAND AND T CELL RESPONSES
-
批准号:2443740
-
项目类别:
-
资助金额:$8.88万
-
财政年份:1994
-
负责人:GERI R BROWN
-
依托单位:
ALPHA INTERFERON EFFECT ON GIANT LIVER HEMANGIOMA
-
批准号:6306967
-
项目类别:
-
资助金额:$3.48万
-
财政年份:--
-
负责人:GERI R BROWN
-
依托单位:
海外基金